Zocon 150 Tablet contains Fluconazole 150 mg, an antifungal agent belonging to the triazole class, indicated for the treatment and prevention of a variety of fungal infections. Fluconazole works by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase, which is essential for converting lanosterol to ergosterol, a key component of the fungal cell membrane. This disruption leads to increased membrane permeability and ultimately fungal cell death. Zocon 150 is commonly prescribed for conditions such as oropharyngeal and esophageal candidiasis, vaginal candidiasis, cryptococcal meningitis, and systemic candidiasis. It is effective against a broad spectrum of Candida species and Cryptococcus neoformans. The tablet is administered orally, with dosage and duration tailored according to the severity and type of infection, as well as patient-specific factors including immune status and renal function. Fluconazole is generally well tolerated, but potential adverse effects include headache, gastrointestinal disturbances, and rare hepatotoxicity. Caution is advised in patients with liver impairment and those on concomitant medications metabolized by the cytochrome P450 system due to possible drug interactions. Zocon 150 should be used under medical supervision, ensuring appropriate diagnosis and monitoring for optimal therapeutic outcomes.